Gaylord Palms Hotel & Convention Center
Room Osceola A
Orlando, FL
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2015 is required.
AMCP Nexus 2015.
Click here to view the below presentation in a larger window.
Hot Topics Include:
- A clinical overview on the treatment of primary immunodeficiency diseases
- Pharmacoeconomic assessment
- Understanding the impact of care mandates
Distinguished Faculty Presenters
|
Mark Ballow, MD Professor of Pediatrics, Department of Pediatrics University of South Florida College of Medicine Division of Allergy & Immunology All Children's Hospital |
|
Jeffrey Dunn, PharmD, MBA Chief Clinical Officer Senior Vice President VRx Pharmacy Services, LLC |
|
Alan Lyles, ScD, MPH, RPh Henry A. Rosenberg Professor of Government, Business, and Nonprofit Partnerships Fellow, National Academy of Public Administration University of Baltimore |
Who Should Attend?
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Nexus 2015.
Statement of Need/Program Overview
Primary immunodeficiency diseases (PI) represent a myriad of life-long conditions that result when a component of the immune system is absent or does not function properly due to a primary or inherited defect. The only treatment for these patients with antibody deficiencies is lifetime administration of immunoglobulin (Ig) replacement therapy; a therapeutic substance derived from human blood plasma and made up of immunoglobulin. Although approximately 150,000 patients are likely to benefit from Ig replacement, only an estimated 35,000 to 55,000 receive ongoing therapy. A lack of awareness and depth of understanding contribute to this underserved population of individuals with PI. This symposium, jointly provided by the Immune Deficiency Foundation, will feature opportunities to overcome barriers to optimal treatment, a pharmacoeconomic assessment of the total cost of care, and practical managed care approaches to provide cost-effective solutions to improve patient outcomes.
Educational Objectives
After completing this activity, the participant should be better able to:
- Characterize the total cost of care for PI, including direct costs associated with drug therapy and associated infections from non-treatment as well as indirect costs, such as those associated with missed work days
- Describe key pharmacoeconomic studies pertaining to Ig replacement therapy and the budgetary implications of these data in a managed care framework
- Characterize the most common payer-driven utilization management strategies for Ig replacement therapy
- Explain how certain management approaches such as site of care mandates, increase member cost-share, and step-therapy requirements adversely impact adherence and outcomes in PI
- Differentiate antibody replacement therapy from other applications of Ig and describe how the differences between IVIG and SCIG may drive the decision of one over the other based on unique patient characteristics
- Characterize the importance of dosing and specifically IgG trough levels in the framework of payer policy and clinical practice for improving outcomes in PI
Date and Time
Thursday, October 29, 2015
6:00 AM - 7:45 AM
Gaylord Palms Hotel & Convention Center
Room Osceola A
Orlando, FL
Agenda
| 6:00 AM | Breakfast and Registration |
| 6:10 AM | Pre-Activity Learning Assessment and Opening Comments |
| 6:15 AM |
Overcoming Barriers to Optimal Antibody Replacement Therapy
Mark Ballow, MD, FAAAAI |
| 6:45 AM |
Pharmacoeconomic Assessment: Considerations to Evaluate the Total Cost of Care Alan Lyles, ScD, MPH |
| 7:05 AM |
Managed Care Approaches for Providing Cost-effective Therapy and Improving Patient Outcomes Jeffrey D. Dunn, PharmD, MBA |
| 7:25 AM |
Moderated Faculty Panel Discussion and Audience Q&A Faculty Panel |
| 7:40 AM |
Closing Comments Post-survey and Evaluations |
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER), the Immune Deficiency Foundation (IDF), and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
 |
Accreditation Statement
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. |
This activity is certified as Knowledge-based CPE.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2015 is required.
Pre-registration will close at 12:00 pm on October 28, 2015.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.